AstraZeneca/Merck Joint Special Education Webinar

The Society of Gynecologic Oncology of Canada

To improve the care of women with or at risk of gynecologic cancer by raising standards of practice, encouraging ongoing research, promoting innovation in prevention, care and discovery, and advancing awareness. GOC also seeks to disseminate knowledge to practitioners, patients and the general public on gynecologic cancer as well as cooperate with other organizations committed to women’s health care, oncology, and related fields.

Event Details

At the end of this lecture, attendees will learn:

To identify the common presentation and symptoms of high grade serous (or advanced) ovarian cancer
To understand the diagnostic modalities for ovarian cancer
To understand the primary treatment of ovarian cancer and identify certain selection criteria for primary surgery versus neoadjuvant chemotherapy

Speakers

Sabrina Piedimonte

Gynecologic Oncology Fellow at University of Toronto

Sarah Sinasac

Gynecologic Oncologist at The Ottawa Hospital

Sabrina Piedimonte is a fellow in gynecologic oncology at the University of Toronto. She holds a B.Sc. in Microbiology and Immunology, M.Sc. in Experimental Surgery and MD CM from McGill University. She completed her residency in obstetrics and gynecology at McGill University in 2020 and during that time received the Eric and Jane Molson award for Excellence in Research and Brian Newton award in Gynecologic Oncology. Previous research has included development of a predictive score to reduce false positives in ovarian cancer testing, implementation of gynecologic oncologist-initiated germline BRCA testing and development of HPV vaccination clinics and a decision-aid tool. She recently completed the Program in Clinical Effectiveness, a joint Harvard/Brigham and Women’s Hospital/Massachusetts General Hospital certificate in August 2020 with focus in predictive modeling, machine learning and survival analysis. Her current research interests include improving precision in advanced ovarian cancer with the development of a prediction model for cytoreductive outcome and a photo-documentation study, application of machine learning in gynecologic oncology and prevention of cervical cancer with HPV vaccination and education.

AstraZeneca Registrant

Standard PriceComplimentary

Merck Registrant